Percent body fat misclassifies patients with sarcopenia as obese: support for fat mass index in obesity assessment
Journal of the Endocrine Society · 08.07.2026 · 10 (8)
DOI: 10.1210/jendso/bvag139 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Endocrine Society, online erschienen am 24.06.2026. Verfasst von Susan L Ziolkowski und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA 94304, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: RRD VA, NIDDK NIH HHS, U.S. Department of Veterans Affairs Rehabilitation Research Development & Translation Merit Awards.
Abstract (Originalsprache)
Background
Percent body fat (%BF) is a common measurement reported on dual-energy X-ray absorptiometry (DXA) to assess for obesity. %BF is calculated as fat mass divided by total body mass, and thereby increases with either higher fat mass or reduced muscle mass. In contrast, fat mass index (FMI; kg/m2) quantifies fat mass independent of muscle mass. It is unknown whether patients classified as obese by %BF have low muscle mass, and whether individuals with sarcopenia are labeled as obese by %BF vs FMI.
Methods
We utilized whole-body DXA data from 1999-2006 NHANES in adults ≥20 years of age (N = 14 850) to estimate the prevalence obesity by %BF, FMI, BMI, and waist circumference. We compared body composition across definitions and examined obesity prevalence among those with sarcopenia.
Results
More patients met criteria for obesity when defined by %BF (76.8%) compared to BMI (33.9%), FMI (35.8%), and WC (51%). Participants classified as obese by %BF had lower lean (muscle) mass, FMI, and BMI compared to participants obese by FMI (all P < .001). Among patients with sarcopenia, 62.4% were classified as obese by %BF compared with 0.5% if BMI was used to define obesity.
Conclusion
Patients who are classified as obese by %BF had the lowest muscle mass and fat mass compared to participants who met other definitions of obesity. The majority of patients with sarcopenia are labeled as obese by %BF. We believe these findings support the use of FMI, a measurement not confounded by muscle mass, for research and clinical assessment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA 94304, USA.
- Division of Endocrinology and Diabetes, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
- Division of Rheumatology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.
- Department of Medicine, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA 19104, USA.
- Department of Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA 19104, USA.
ORCID-Profile: Susan L Ziolkowski
Förderung
- RRD VA
- NIDDK NIH HHS
- U.S. Department of Veterans Affairs Rehabilitation Research Development & Translation Merit Awards
- National Institutes of Health
Zitieren
APA
Ziolkowski, S. L., Weber, D. R., & Baker, J. F. (2026). Percent body fat misclassifies patients with sarcopenia as obese: support for fat mass index in obesity assessment. Journal of the Endocrine Society, 10(8). https://doi.org/10.1210/jendso/bvag139
Vancouver
Ziolkowski SL, Weber DR, Baker JF. Percent body fat misclassifies patients with sarcopenia as obese: support for fat mass index in obesity assessment. Journal of the Endocrine Society. 2026;10(8). doi:10.1210/jendso/bvag139
BibTeX
@article{Ziolkowski2026,
author = {Ziolkowski, Susan L and Weber, David R and Baker, Joshua F},
title = {Percent body fat misclassifies patients with sarcopenia as obese: support for fat mass index in obesity assessment},
journal = {Journal of the Endocrine Society},
year = {2026},
volume = {10},
number = {8},
doi = {10.1210/jendso/bvag139}
}
EUVIMED